News | July 10, 2009

CMS Stats Show One in Five Medicare Patients Readmitted Within a Month

July 10, 2009 – New information added this week to the Centers for Medicare and Medicaid Services’ (CMS) Hospital Compare Web site shows patients frequently return to a hospital after discharge, a possible indicator of how well the facility did the first time around.

On average, one in five Medicare beneficiaries discharged from a hospital today will return within a month. Reducing the rate of hospital readmissions to improve quality and achieve savings are key components of President Obama’s healthcare reform agenda.

"The President and Congress have both identified the reduction of readmissions as a target area for health reform," said U.S. Health and Human Services (HHS) Secretary Kathleen Sebelius. "When we reduce readmissions, we improve the quality of care patients receive and cut healthcare costs."

With the update announced today, Hospital Compare will provide better data on the previously posted mortality rates for individual hospitals, as well as the new data on 30-day readmissions for heart attack, heart failure and pneumonia. Previously, Hospital Compare had provided only mortality rates for these three conditions.

Research shows that hospital readmissions reduce the quality of health care while increasing hospital costs. Hospital Compare data show that 19.9 percent of patients admitted for heart attack treatment will return to the hospital within 30 days, and 24.5 percent admitted for heart failure will return within 30 days.

“The American College of Cardiology (ACC) supports public reporting of these measures because they are intended to drive quality improvement efforts to enhance care in these important and high volume clinical areas,” said Alfred Bove, M.D., ACC president. “Reporting of the readmission measures provides hospitals with critical information about the quality of care they provide. As Congress gets set to vote on overarching health reform bills in the coming weeks, these data are critical to helping benchmark and ensure quality care.”

The ACC is encouraging its members to review and act on the data. It is also gearing up to help hospitals respond to the measures by guiding efforts to improve patient care and by providing leadership and technical assistance. The ACC's new Hospital to Home (H2H) initiative will provide evidence-based strategies for reducing cardiovascular readmissions by 20 percent by 2012. This comprehensive new effort, which is in partnership with the Institute for Healthcare Improvement (IHI), is designed to improve the transition from hospital to home and improve outcomes of cardiovascular health.

For more information: www.hospitalcompare.hhs.gov, www.cms.hhs.gov, www.acc.org

Related Content

FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
DABRA Excimer Laser System Demonstrates Success in Treating PAD
News | Cath Lab | February 27, 2019
Ra Medical Systems Inc. announced a 98 percent success rate in the results from a 52-patient study using the company’s...
Edwards Lifesciences Recalls Swan-Ganz hemodynamic catheters.
Feature | Cath Lab | February 06, 2019
Edwards Lifesciences is recalling its 131F7, 131F7J, 131F7P, 131VF7P, 151F7 Swan-Ganz Thermodilution Catheters manufa
Scientists Discover New Heart Attack Repair Pathway

A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.

News | Cath Lab | January 30, 2019
Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing after a heart attack....
Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
Overlay Init